MONOCLONAL ANTIBODIES AS ANTI-
TYROSINE KINASE RECEPTOR  DRUGS
Anti-RTK mAbs block the
ligand-receptor interaction
ð inhibition of ligand-induced
RTK signaling
ð increase of RTK down
regulation and internalization
Zwick et al, Trends in Molecular Medicine (2002) 8: 17-23
2003-2004